Latest papers

Biovigilance and pharmacovigilance for haemophilia.

The role of prophylaxis in bleeding disorders.

New developments in laboratory diagnosis and monitoring.

Prothrombin complex concentrates: an update.

Variant Creutzfeldt-Jakob disease.

The application of genetics to inherited bleeding disorders.

Taking the thrombin fork.

Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response.

Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature.

Activated protein C improves the severity of severe acute pancreatitis via up-regulating the expressions of endothelial cell protein C receptor and thrombomodulin.

Dissecting the effects of lipopolysaccharides from nonlipopolysaccharide molecules in experimental porcine meningococcal sepsis.

Coagulopathy in liver diseases.

Molecular aspects in clinical hemostasis research at Karolinska Institutet

Reversal of vitamin K antagonists prior to urgent surgery.

Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates.

Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.

Blood patch treatment of chylothorax following transthoracic oesophagogastrectomy: a novel technique to aid surgical management.

Hereditary coagulopathies: practical diagnosis and management for the plastic surgeon.

[Liver failure in a woman with acute fatty liver of pregnancy].

The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.